Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
脂质体伊立替康联合氟尿嘧啶/亚叶酸钙与 FOLFIRINOX 方案作为转移性胰腺癌患者二线化疗的比较:韩国癌症研究组 (KCSG) 的一项多中心回顾性研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100049
Park, H S; Kang, B; Chon, H J; Im, H-S; Lee, C-K; Kim, I; Kang, M J; Hwang, J E; Bae, W K; Cheon, J; Park, J O; Hong, J Y; Kang, J H; Kim, J H; Lim, S H; Kim, J W; Kim, J-W; Yoo, C; Choi, H J